Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
Virtual and Standard Colonoscopy Both Accurate
Denosumab May Help Prevent Bone Loss
Past Highlights
Results:
1 -10 of 32
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Sort By:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Version:
Health Professional
Patient
Format:
Short
------
Short
Medium
Long
Custom
1.
Phase II-III Therapy with 5-FU vs 5-FU/TZT vs 5-FU/ICRF-159 vs MeCCNU/ICRF-159 vs MeCCNU/TZT vs ICRF-159/TZT for Advanced Colorectal Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III, Phase II
Treatment
Closed
no age specified
NCI
NCCTG-784651
2.
Phase II-III Study with 5-FU/ICRF-159/MeCCNU, 5-FU/ADR with or without MITO or MeCCNU, and 5-FU/MeCCNU for Unresectable Gastric Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III, Phase II
Treatment
Closed
no age specified
GITSG-8376
MAYO-764101
Last Modified:
5/15/2007
3.
Phase III Chemotherapy with Various Schedules of ADR for Soft Tissue and Bone Sarcoma and Mesothelioma
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III, Phase II
Treatment
Completed
14 to 75
NCI
EST-3377
4.
Phase II-III Chemotherapy with Ftorafur vs 5-FU/MeCCNU/TZT vs 5-FU/MeCCNU/ICRF-159 vs 5-FU/MeCCNU/VCR for Advanced Colorectal Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III, Phase II
Treatment
Closed
no age specified
MAYO-764802
5.
Phase III 5-FU vs 5-FU/HU vs 5-FU/HU/MeCCNU/DTIC vs MeCCNU/DTIC vs MeCCNU/ICRF vs MITO/DTIC for Advanced Colon and Rectal Adenocarcinoma
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Closed
no age specified
NCI
EST-1278
EST-1278
6.
Phase I-II Combination Chemotherapy with MITO plus ICRF in Previously Treated Patients with Colorectal Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II, Phase I
Treatment
Closed
no age specified
NCI-D78-048-090
WCCC-CO-7722
7.
Phase I-II Chemotherapy with ICRF-159/Adriamycin for Advanced Metastatic Adenocarcinoma of the Gastrointestinal Tract
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II, Phase I
Treatment
Closed
no age specified
SEG-78GI0102
SEG-78GI238
8.
Phase II Chemotherapy with ICRF-159 for Nonlymphomatous Sarcomas and Other Solid Tumors
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II, Phase I
Treatment
Closed
no age specified
WLT-26
9.
Phase I Study of Combination Therapy with Adriamycin plus ICRF-159 for Nonlymphomatous Solid Malignant Tumors
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II, Phase I
Treatment
Closed
no age specified
WLT-29
10.
Phase I/II Optimal Dose Level Pilot Study of 5-FU, ICRF-159, MeCCNU plus Triazinate in Various Two-Drug Combinations for Large Bowel Carcinoma
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II, Phase I
Treatment
Completed
no age specified
MAYO-770304
Select All on One Page
1
2
3
4
Next >
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute